" class="no-js "lang="en-US"> Roger Nitsch - Medtech Alert
Friday, March 29, 2024
Roger Nitsch

Roger Nitsch

About Roger Nitsch

Roger M Nitsch serves as CEO & President of Neurimmune. A neuroscientist with a background in medicine, Roger is recognized as a key opinion leader in neurodegenerative diseases with more than 30 years of experience in Alzheimer’s disease research, and as a pioneer in the development of therapeutic approaches for neurodegenerative diseases. The Potamkin prize winner and Member of the German Academy of Sciences served as a founding director of the Institute for Regenerative Medicine (IREM), University of Zurich where he holds a part-time professorship teaching bio-entrepreneurship. Roger founded Neurimmune in 2006 together with Jan Grimm and Christoph Hock.

Related Story

FDA Approval of Aducanumab

June 10 2021

Neurimmune welcomes the news that the U.S. Food and Drug Administration (FDA) has approved Biogen‘s […]